Austedo
Product Images NDC 68546-182

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Austedo (NDC 68546-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Neuroscience, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure.jpg (Image 1)

FDA Label Image

Image (Image 10)

FDA Label Image

Hd 4-week Kit (Image 11)

FDA Label Image

Td 4-week Kit (Image 12)

FDA Label Image

Figure-01.jpg (Image 2)

This is a graph depicting the mean total maximal chorea score during a dose titration study of AUSTEDO compared to a placebo washout. AUSTEDO was administered to 45 patients while the same number were given a placebo. The study lasted for 13 weeks and the AUSTEDO group demonstrated a statistically significant improvement in chorea score compared to the placebo group.*

FDA Label Image

Figure-02.jpg (Image 3)

FDA Label Image

Figure-03.jpg (Image 4)

FDA Label Image

Figure-04.jpg (Image 5)

FDA Label Image

Image (Image 6)

FDA Label Image

Image (Image 7)

Product name: Austedo Active ingredient: Deutetrabenazine Strength: 9mg Dosage form: Tablet This text appears to be incomplete and does not provide a complete description of the product.*

FDA Label Image

Image (Image 8)

FDA Label Image

Image (Image 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.